Poltreg S.A. (PTG.WA) — Stock Score Summary

Poltreg S.A. (PTG.WA) has a MoatMap StockRank of 5/100 based on Quality (25/100), Value (38/100), and Momentum (19/100) factor scores. The current signal is STRONG SELL. Poltreg S.A. is an early-stage Polish biotechnology company developing T-cell therapies. It does not possess the validated, high-utilization manufacturing scale of a CDMO, nor does it have the predictable cash flows required of a quality compounder.

Poltreg S.A. is a clinical-stage Polish biotechnology company pioneering the development of T-regulatory (Treg) cell therapies for autoimmune diseases, including Type 1 diabetes and multiple sclerosis. The company possesses a strong competitive moat through its proprietary Treg cell-expansion platform and its own state-of-the-art, GMP-certified manufacturing facility. Poltreg represents a high-barrier-to-entry biotech innovator targeting massive, underserved global therapeutic markets.

Key Financial Metrics

Price$5.07
Market Cap$28M
P/E (Forward)4.95
Price/Book2.41
Return on Equity-54.4%
Return on Invested Capital-40.1%
Debt/Equity20.78
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-1M

Poltreg S.A. operates in the Biotechnology industry, part of the Healthcare sector (Poland).

Frequently Asked Questions

What is Poltreg S.A.’s (PTG.WA) StockRank?
MoatMap’s StockRank for Poltreg S.A. (PTG.WA) is 5/100, with a Strong Sell signal. It is a composite of Quality (25), Value (38), and Momentum (19) factor ranks across MoatMap’s 19,000+ stock universe.
Does Poltreg S.A. have an economic moat?
Poltreg S.A. (PTG.WA) has a Quality factor score of 25/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Poltreg S.A. a buy, hold, or sell?
MoatMap’s current signal for Poltreg S.A. (PTG.WA) is Strong Sell, based on a StockRank of 5/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Poltreg S.A. in?
Poltreg S.A. (PTG.WA) operates in the Healthcare sector, specifically the Biotechnology industry (Poland).
Browse all ranked stocksPTG.WA deep dive reportAI ChampionsHow we score stocksSense-check another stock